What we're reading, February 11, 2016: Plaintiffs lose their case against cigarette manufacturer; the politics behind providing care for those infected with Zika; and of course, prescription drug prices.
Longtime smokers of Marlboro cigarettes have lost their liability fight against the cigarette manufacturer Philip Morris USA. According to a report in the Chicago Tribune, a jury unanimously rejected a claim filed 10 years back that Marlboros are defective and dangerous. If they had won, the plaintiffs would have been eligible to receive screening chest scans estimated to cost $500.
Meanwhile, as the Zika virus continues its rampage in Latin America, the CDC believes Puerto Rico might be hit hard by the outbreak along with some other US territories. According to Reuters, CDC director Tom Frieden, MD, MPH, shared the information with the House Foreign Affairs subcommittee. Republican lawmakers who led the hearing, meanwhile, played abortion politics saying they hoped that infected women will not have abortions to avoid giving birth to children with developmental problems.
At another hearing on the Hill, HHS secretary Silvia Mathews Burwell was up defending the president’s budget—she told lawmakers that the administrations is delving into every option that can help control prescription drug prices. Burwell responded to Senator Jim McDermott’s (D-Washington) statement of support for Medicare to be able to negotiate prescription drug prices, saying that prescription prices are an increasing part of the Medicare budget and Veterans Administration has successfully negotiated lower prices.
Trump Administration’s Message to Supreme Court Puts New Wrinkle in Braidwood Case
February 21st 2025The Trump administration argues that HHS Secretary Robert F. Kennedy Jr can overrule the US Preventive Services Task Force to determine the preventive services covered under the Affordable Care Act.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
5 Key Health Care Moments During President Trump's First Month Back in Office
February 21st 2025President Donald J. Trump pushed for significant health care changes during his first month back in office, through executive orders affecting managed care, drug pricing, and clinical trial diversity guidance.
Read More
Same-Day Breast Imaging Gaps Reveal Health Care Disparities
February 18th 2025For this retrospective study, the authors examined data on more than 3 million screening mammographies for more than 1 million female patients; of the screenings, 23.6% had abnormal results and only 6.7% were recommended for biopsy.
Read More